-
201
Obstructive sleep apnea, the NLRP3 inflammasome and the potential effects of incretin therapies
Published 2025-01-01Subjects: “…glucagon like peptide-1 receptor agonists…”
Get full text
Article -
202
Correction of Thrombocytopenia before Elective Surgery / Invasive Procedures in Patients with Liver Cirrhosis (Experts’ Agreement)
Published 2024-08-01Subjects: “…thrombopoietin receptor agonists…”
Get full text
Article -
203
Use of Glucagon-Like Peptide-1 Receptor Agonists Does Not Increase the Risk of Cancer in Patients with Type 2 Diabetes Mellitus
Published 2025-01-01Subjects: “…glucagon-like peptide-1 receptor agonists…”
Get full text
Article -
204
Pathology and Treatments of Alzheimer’s Disease Based on Considering Changes in Brain Energy Metabolism Due to Type 2 Diabetes
Published 2024-12-01Subjects: “…glucagon-like peptide 1 receptor agonists…”
Get full text
Article -
205
State Power Legitimacy Crisis in the Era of Globalization
Published 2020-09-01Subjects: Get full text
Article -
206
Anti-Diabetic Therapies and Cancer: From Bench to Bedside
Published 2024-11-01Subjects: Get full text
Article -
207
Impaired Sequential Working Memory in Patients With Young Onset Parkinson's Disease
Published 2024-12-01Subjects: “…dopamine D2/3 receptor agonists…”
Get full text
Article -
208
Correction of Thrombocytopenia with Thrombopoietin Receptor Agonists in Patients with Liver Cirrhosis Before Elective Surgery or Invasive Procedures
Published 2025-02-01Subjects: “…thrombopoietin receptor agonists…”
Get full text
Article -
209
The Application of Incretin-Based Pharmacotherapy in the Contemporary Management of Type 2 Diabetes: A Review of the Literature
Published 2025-01-01Subjects: Get full text
Article -
210
Suicide and suicide attempt in users of GLP-1 receptor agonists: a nationwide case-time-control studyResearch in context
Published 2025-02-01Subjects: “…Glucagon-like peptide-1 receptor agonists…”
Get full text
Article -
211
Adverse effects of GLP – 1 Receptor Agonists
Published 2025-02-01Subjects: “…obesity, glucagon – like peptide – 1 receptor agonists…”
Get full text
Article -
212
Clinical significance of serum estradiol monitoring in women receiving adjuvant aromatase inhibitor for hormone receptor-positive early breast cancer
Published 2024-12-01Subjects: “…Gonadotropin-releasing hormone agonists…”
Get full text
Article -
213
-
214
Mitigating Increased Cardiovascular Risk in Patients with Obstructive Sleep Apnea Using GLP-1 Receptor Agonists and SGLT2 Inhibitors: Hype or Hope?
Published 2024-11-01Subjects: “…glucagon-like peptide-1 receptor agonists…”
Get full text
Article -
215
Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AW...
Published 2024-12-01Subjects: “…Glucagon Like Peptide 1 Receptor Agonists…”
Get full text
Article -
216
Luteinizing hormone-releasing hormone receptor agonists and antagonists in prostate cancer: effects on long-term survival and combined therapy with next-generation hormonal agents
Published 2024-11-01Subjects: “…luteinizing hormone-releasing hormone receptor agonists…”
Get full text
Article -
217
Understanding the link between type 2 diabetes mellitus and Parkinson’s disease: role of brain insulin resistance
Published 2025-11-01Subjects: Get full text
Article -
218
Association of incretin-based therapies with hepatobiliary disorders among patients with type 2 diabetes: a case series from the FDA adverse event reporting system
Published 2024-11-01Subjects: “…glucagonlike peptide-1 receptor agonists…”
Get full text
Article -
219
Optimization and calibration of 384-well kinetic Ca2+ mobilization assays for the human transient receptor potential cation channels TRPM8, TRPV1, and TRPA1
Published 2025-01-01Subjects: “…Benchmarking with known agonists and antagonists…”
Get full text
Article